Lutein Suppresses Oxidative Stress and Inflammation by Nrf2 Activation in an Osteoporosis Rat Model

被引:56
作者
Li, Hongtao [1 ]
Huang, Caihong [2 ]
Zhu, Jun [1 ]
Gao, Kehai [1 ]
Fang, Jun [1 ]
Li, Huazhuang [1 ]
机构
[1] Yidu Cent Hosp Weifang, Dept Spine Surg, Qingzhou, Shandong, Peoples R China
[2] Yidu Cent Hosp Weifang, Dept Hlth Management, Qingzhou, Shandong, Peoples R China
来源
MEDICAL SCIENCE MONITOR | 2018年 / 24卷
关键词
Lutein; NF-E2 Transcription Factor; Osteoporosis; RANK Ligand; Reactive Oxygen Species; BONE LOSS; OSTEOCLASTOGENESIS; DISEASES; RANKL;
D O I
10.12659/MSM.908699
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Osteoporosis is a major health risk for women worldwide. Osteoporosis is caused by an imbalance between bone resorption and formation. Hormonal imbalance and increased redox signaling cause bone deterioration. Material/Methods: Oxidative stress was determined through assessment of ROS, lipid peroxide levels, and antioxidant activity. Inflammatory protein markers and Nrf2-related protein expressions were determined through Western blot analysis. Interleukin expressions were determined using ELSA. Results: In the present study, we showed that supplementation of lutein protects the ovariectomized (OVX) rats against oxidative stress through its antioxidant protection. OVX rats showed an increase in oxidative stress markers. Lutein treatment significantly decreased the lipid peroxidation levels and ROS in the OVX rats. OVX rats showed inflammatory responses through NF-kappa B activation and increased inflammatory cytokines (TNF-alpha, IL-6, IL-8). Further, there was significant upregulation in osteoclast-specific marker NFATc1 in OVX rats compared to sham rats. Lutein supplementation activated Nrf2 driven antioxidant gene expression (HO-1, NQO1) and protected OVX rats against inflammatory responses. Conclusions: We showed the critical role of Lutein in protection against osteoporosis in OVX rats by downregulation of inflammation and osteoclast-specific marker (NFATc1) expression through Nrf2 activation.
引用
收藏
页码:5071 / 5075
页数:5
相关论文
共 17 条
[1]   Role of RANKL in bone diseases [J].
Anandarajah, Allen P. .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2009, 20 (02) :88-94
[2]   Lutein exerts anti-inflammatory effects in patients with coronary artery disease [J].
Chung, Rosanna W. S. ;
Leanderson, Per ;
Lundberg, Anna K. ;
Jonasson, Lena .
ATHEROSCLEROSIS, 2017, 262 :87-93
[3]   Aging and bone loss: new insights for the clinician [J].
Demontiero, Oddom ;
Vidal, Christopher ;
Duque, Gustavo .
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2012, 4 (02) :61-76
[4]  
Eastell R, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.70, 10.1038/nrdp.2016.69]
[5]   Reactive oxygen species mediate RANK signaling in osteoclasts [J].
Ha, H ;
Kwak, HB ;
Lee, SW ;
Jin, HM ;
Kim, HM ;
Kim, HH ;
Lee, ZH .
EXPERIMENTAL CELL RESEARCH, 2004, 301 (02) :119-127
[6]   Antioxidant properties of lutein contribute to the protection against lipopolysaccharide-induced uveitis in mice [J].
He, Rong-Rong ;
Tsoi, Bun ;
Lan, Fang ;
Yao, Nan ;
Yao, Xin-Sheng ;
Kurihara, Hiroshi .
CHINESE MEDICINE, 2011, 6
[7]   Kinsenoside prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis by regulating classical NF-κB pathways [J].
Hsiao, H. -B. ;
Lin, H. ;
Wu, J. -B. ;
Lin, W. -C. .
OSTEOPOROSIS INTERNATIONAL, 2013, 24 (05) :1663-1676
[8]   Lutein acts via multiple antioxidant pathways in the photo-stressed retina [J].
Kamoshita, Mamoru ;
Toda, Eriko ;
Osada, Hideto ;
Narimatsu, Toshio ;
Kobayashi, Saori ;
Tsubota, Kazuo ;
Ozawa, Yoko .
SCIENTIFIC REPORTS, 2016, 6
[9]   Luteolin attenuates endotoxin-induced uveitis in Lewis rats [J].
Kanai, Kazutaka ;
Hatta, Takuya ;
Nagata, Sho ;
Sugiura, Yuichi ;
Sato, Kazuaki ;
Yamashita, Yohei ;
Kimura, Yuya ;
Itoh, Naoyuki .
JOURNAL OF VETERINARY MEDICAL SCIENCE, 2016, 78 (08) :1229-1235
[10]   Putative protective role of lutein and zeaxanthin in diabetic retinopathy [J].
Neelam, Kumari ;
Goenadi, Catherina J. ;
Lun, Katherine ;
Yip, Chee Chew ;
Eong, Kah-Guan Au .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2017, 101 (05) :551-558